|

PanTheR Registry Trial

RECRUITINGSponsored by RenovoRx
Actively Recruiting
SponsorRenovoRx
Started2025-08-01
Est. completion2029-09-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT06805461

Summary

This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Eligibility Criteria:

1. Male and female patients who have been diagnosed with solid tumor cancers and are at least 18 years of age at the time of the first IA procedure
2. Patients willing to provide informed consent and HIPAA release for use of their relevant medical records

Conditions2

CancerSolid Tumors

Locations3 sites

Florida

1 site
Baptist Health South Florida
Coral Gables, Florida, 33143
Dr. Gandhi

Pennsylvania

1 site
University of Pennsylvania Medical Center
Pittsburgh, Pennsylvania, 15213
Dr. Novelli

Vermont

1 site
The University of Vermont Medical Center
Burlington, Vermont, 05401
Dr. O'Neill

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.